These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 21075164)
1. Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010). Hanquet G; Van Damme P; Brasseur D; De Cuyper X; Gregor S; Holmberg M; Martin R; Molnár Z; Pompa MG; Snacken R; van der Sande M; Van Ranst M; Wirtz A; Neels P Vaccine; 2011 Jan; 29(3):370-7. PubMed ID: 21075164 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects. Fukase H; Furuie H; Yasuda Y; Komatsu R; Matsushita K; Minami T; Suehiro Y; Yotsuyanagi H; Kusadokoro H; Sawata H; Nakura N; Lattanzi M Vaccine; 2012 Jul; 30(33):5030-7. PubMed ID: 22472791 [TBL] [Abstract][Full Text] [Related]
3. [Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey]. Ertek M; Sevencan F; Kalaycıoğlu H; Gözalan A; Simşek C; Culha G; Dorman V; Ozlü A; Arıkan F; Aktaş D; Akın L; Korukluoğlu G; Sevindi DF Mikrobiyol Bul; 2011 Oct; 45(4):684-96. PubMed ID: 22090299 [TBL] [Abstract][Full Text] [Related]
4. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011. Girard MP; Katz JM; Pervikov Y; Hombach J; Tam JS Vaccine; 2011 Oct; 29(44):7579-86. PubMed ID: 21856358 [TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age. Knuf M; Leroux-Roels G; Rümke HC; Abarca K; Rivera L; Lattanzi M; Pedotti P; Arora A; Kieninger-Baum D; Della Cioppa G Vaccine; 2015 Jan; 33(1):174-81. PubMed ID: 25444803 [TBL] [Abstract][Full Text] [Related]
6. Pandemic influenza vaccination during pregnancy: an investigation of vaccine uptake during the 2009/10 pandemic vaccination campaign in Great Britain. Sammon CJ; McGrogan A; Snowball J; de Vries CS Hum Vaccin Immunother; 2013 Apr; 9(4):917-23. PubMed ID: 23364304 [TBL] [Abstract][Full Text] [Related]
7. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months. Esposito S; Pugni L; Daleno C; Ronchi A; Valzano A; Serra D; Mosca F; Principi N Pediatrics; 2011 May; 127(5):e1161-8. PubMed ID: 21464195 [TBL] [Abstract][Full Text] [Related]
8. Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic. Goldfarb I; Panda B; Wylie B; Riley L Am J Obstet Gynecol; 2011 Jun; 204(6 Suppl 1):S112-5. PubMed ID: 21345408 [TBL] [Abstract][Full Text] [Related]
9. Pandemic 2009-2010 influenza vaccine: six lessons learned and the way forward (Allegro not Adagio). Poland GA Vaccine; 2011 Jan; 29(4):613-4. PubMed ID: 21193121 [No Abstract] [Full Text] [Related]
10. New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain. Poland GA; Fleming DM; Treanor JJ; Maraskovsky E; Luke TC; Ball EM; Poland CM Vaccine; 2013 Apr; 31 Suppl 1():A1-20. PubMed ID: 23587330 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young children. Scheifele DW; Ward BJ; Dionne M; Vanderkooi O; Langley JM; Dobson S; Li Y; Law B; Halperin SA; Pediatr Infect Dis J; 2011 May; 30(5):402-7. PubMed ID: 21178654 [TBL] [Abstract][Full Text] [Related]
12. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean. Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798 [TBL] [Abstract][Full Text] [Related]
13. Modeling optimal age-specific vaccination strategies against pandemic influenza. Lee S; Golinski M; Chowell G Bull Math Biol; 2012 Apr; 74(4):958-80. PubMed ID: 22147102 [TBL] [Abstract][Full Text] [Related]
14. Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers. Steelfisher GK; Blendon RJ; Bekheit MM; Mitchell EW; Williams J; Lubell K; Peugh J; DiSogra CA Am J Obstet Gynecol; 2011 Jun; 204(6 Suppl 1):S116-23. PubMed ID: 21492827 [TBL] [Abstract][Full Text] [Related]
15. Safety of pandemic H1N1 vaccines in children and adolescents. Wijnans L; de Bie S; Dieleman J; Bonhoeffer J; Sturkenboom M Vaccine; 2011 Oct; 29(43):7559-71. PubMed ID: 21821086 [TBL] [Abstract][Full Text] [Related]
16. Vaccines against influenza A (H1N1) pandemic. Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259 [TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects. Hatz C; von Sonnenburg F; Casula D; Lattanzi M; Leroux-Roels G Vaccine; 2012 May; 30(23):3470-7. PubMed ID: 22446638 [TBL] [Abstract][Full Text] [Related]
18. Influenza and pregnancy in the United States: before, during, and after 2009 H1N1. Rasmussen SA; Jamieson DJ Clin Obstet Gynecol; 2012 Jun; 55(2):487-97. PubMed ID: 22510632 [TBL] [Abstract][Full Text] [Related]